The William M. Feinberg Award for Excellence in Clinical Stroke is named for a prominent stroke clinician-researcher and American Heart Association volunteer who contributed to a fuller understanding of the causes of stroke. The award recognizes significant contributions to the investigation and management of clinical research in stroke.
Wardlaw’s research focuses on the diagnosis, prevention and treatment of cerebrovascular disease, starting in the early 1990s with one of the first randomized controlled trials of intra-arterial thrombolysis for stroke. She has served on steering committees for several thrombolysis trials, researching ways to improve cost-effective use of imaging for stroke diagnosis and prevention. Increasingly, she targets the determining mechanisms of small vessel disease, a common cause of stroke and dementia, with a view to improving prevention and treatment of all its manifestations.
Wardlaw gave the William M. Feinberg Lecture titled “Small Vessel Disease: A Big Problem, but Fixable” on 25 January 2018 at the International Stroke Conference in Los Angeles, CA, USA.